Filing Details

Accession Number:
0001209191-23-018041
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-10 21:00:12
Reporting Period:
2023-03-09
Accepted Time:
2023-03-10 21:00:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1630627 Treace Medical Concepts Inc. TMCI Surgical & Medical Instruments & Apparatus (3841) 471052611
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1916619 Michael Scot Elder C/O Treace Medical Concepts, Inc.
100 Palmetto Park Place
Ponte Vedra FL 32081
*See "Remarks" No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-09 177 $24.41 22,421 No 4 S Direct
Common Stock Acquisiton 2023-03-10 27,500 $0.00 49,921 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Stock Option (Right To Buy) Stock Option (Right to Buy) Acquisiton 2023-03-10 62,300 $0.00 62,300 $24.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
62,300 2033-03-10 No 4 A Direct
Footnotes
  1. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  2. Includes 18,143 RSUs.
  3. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.
  4. Includes 45,643 RSUs.
  5. The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.